| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11906-005-0005-4 |
| P8608 | Fatcat ID | release_imwbjzeecrelndnip5ov22dhxy |
| P698 | PubMed publication ID | 15913489 |
| P50 | author | Gregory Lip | Q60393087 |
| P2093 | author name string | George I Varughese | |
| P2860 | cites work | The L-arginine-nitric oxide pathway | Q24304874 |
| Platelets and atrial fibrillation | Q28191810 | ||
| Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation | Q28196402 | ||
| Vascular endothelial cells synthesize nitric oxide from L-arginine | Q28291036 | ||
| Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction | Q32071845 | ||
| Nitric oxide and hypertension: not just an endothelium derived relaxing factor! | Q33943918 | ||
| Platelet dysfunction in type 2 diabetes | Q34319534 | ||
| Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation | Q35582996 | ||
| Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle | Q40387875 | ||
| Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. | Q40694210 | ||
| Intracellular calcium, currents, and stimulus-response coupling in endothelial cells | Q40850738 | ||
| Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease | Q41072972 | ||
| Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression. | Q41714968 | ||
| Platelet aggregation in relationship to plasma catecholamines in patients with hypertension | Q41723988 | ||
| Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy | Q43562633 | ||
| Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate | Q44009240 | ||
| Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). | Q44053700 | ||
| Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor? | Q44128109 | ||
| Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). | Q45056031 | ||
| Haemorheological and fibrinolytic activity in hypertensive Nigerians | Q50655250 | ||
| Inflammation, the endothelium, and the acute coronary syndromes. | Q52533338 | ||
| Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy | Q52694276 | ||
| Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population | Q57740582 | ||
| Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation. | Q64917586 | ||
| The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: An in vitro study | Q67897250 | ||
| Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism | Q67898854 | ||
| Increased platelet cytosolic free calcium concentration in essential hypertension | Q69695432 | ||
| Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration | Q70782550 | ||
| Enhanced Levels of Tissue-Type Plasminogen Activator in Borderline Hypertension | Q71819548 | ||
| Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms | Q73199837 | ||
| Inhibition of platelet aggregability by losartan in essential hypertension | Q73222152 | ||
| Basal nitric oxide synthesis in essential hypertension | Q73273898 | ||
| Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden | Q73484494 | ||
| Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan | Q73660473 | ||
| Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines | Q73815958 | ||
| Evidence of platelet activation in hypertension | Q73864720 | ||
| Relation of Endothelium, Thrombogenesis, and Hemorheology in Systemic Hypertension to Ethnicity and Left Ventricular Hypertrophy | Q73995202 | ||
| Relationship Between Endothelial Function and Fibrinolysis in Early Hypertension | Q74132643 | ||
| Fibrinolytic/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol | Q74137868 | ||
| Are ACE inhibitors a "magic bullet" against oxidative stress? | Q74553430 | ||
| Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited | Q78945394 | ||
| Effects of severe hypertension on endothelial and platelet microparticles | Q78945402 | ||
| Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure | Q79322013 | ||
| Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism | Q80557533 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 168-173 | |
| P577 | publication date | 2005-06-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Current Hypertension Reports | Q15746362 |
| P1476 | title | Is hypertension a prothrombotic state? | |
| P478 | volume | 7 |
| Q84742760 | A clinical cardiology perspective of thrombophilias |
| Q38967851 | Association of ambulatory arterial stiffness index with sEPCR in newly diagnosed hypertensive patients |
| Q35022280 | Brain injury after intracerebral hemorrhage in spontaneously hypertensive rats. |
| Q35773343 | Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation |
| Q41079076 | Effects of high flavanol dark chocolate on cardiovascular function and platelet aggregation |
| Q40028542 | Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension. |
| Q36383621 | HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation |
| Q44155888 | Higher coated-platelet levels are associated with chronic hypertension in patients with transient ischemic attack |
| Q44552747 | Mean platelet volume and abnormal left ventricle geometric patterns in patients with untreated essential hypertension |
| Q86761394 | Mean platelet volume in patients with primary aldosteronism and its relation to left ventricular hypertrophy |
| Q35107836 | PPARγ ligands decrease hydrostatic pressure-induced platelet aggregation and proinflammatory activity |
| Q38089733 | Proteomics as a tool to discover biomarkers for the prediction of diabetic complications |
| Q37680596 | Relationship between mean platelet volume and morning blood pressure surge in newly diagnosed hypertensive patients. |
| Q91819889 | The association between mean platelet volume and inflammation in geriatric patients with emergency hypertension |
| Q26824050 | Tissue factor, protease activated receptors and pathologic heart remodelling |
Search more.